Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common stock, $0.00001 par value per share
-
Shares outstanding
-
60,389,334
-
Total 13F shares
-
46,893,465
-
Share change
-
+3,964,391
-
Total reported value
-
$5,808,669,841
-
Put/Call ratio
-
133%
-
Price per share
-
$123.86
-
Number of holders
-
230
-
Value change
-
+$482,976,075
-
Number of buys
-
127
-
Number of sells
-
100
Institutional Holders of Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST) as of Q1 2021
As of 31 Mar 2021,
Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST) was held by
230 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,893,465 shares.
The largest 10 holders included
ARK Investment Management LLC, BlackRock Inc., VANGUARD GROUP INC, Capital World Investors, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., Invesco Ltd., JPMORGAN CHASE & CO, Allianz Asset Management GmbH, and CREDIT SUISSE AG/.
This page lists
233
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.